More than one hundred leaders in European cancer policy gathered together 11 October at the fourth Oncopolicy Forum, to discuss the scientific, ethical, financial and practical challenges of making personalised cancer medicine a reality.
Distinguished speakers from the EU institutions, patient groups, and the scientific and oncology communities presented to delegates how unprecedented levels of cooperation, both within and outside oncology, will be needed to tackle the scientific, ethical, financial, and practical challenges of personalised medicine. The significance of personalised medicine is undeniable. However, many hurdles must be overcome to enable rapid development and implementation of its results.
Page last modified: